Effect of interleukin 2 on the production of progesterone and prostaglandin E2 in human fetal membranes and its consequences for preterm uterine contractions.
Our objective was to clarify the mechanism of uterine contraction induced in pregnant women by intrauterine bacterial infection. The concentration of interleukin 2 (IL-2) was measured in amniotic fluids that had been obtained by amniocentesis, transvaginal amniotomy or by transuterine amniocentesis performed at cesarean section in 50 pregnant women. The concentration of IL-2 in those cases with intrauterine infection was significantly higher than that of those without intrauterine infection at preterm. The same tendency was found at term. Scatchard analysis demonstrated the presence of an IL-2 receptor in the fetal membranes. We collected the fetal membranes aseptically for the measurement of progesterone and prostaglandin E2 by radioimmunoassay following incubation with various concentrations of interleukin 1 (IL-1) and IL-2 at 37 degrees C for 16 h. The production of progesterone was inhibited significantly by 10 pmol/l IL-2 but not by 10 pmol/l IL-1. The production of prostaglandin E2 was accelerated significantly by either IL-1 or IL-2 at a dose of 10 pmol/l. The inhibitory effect of IL-2 on the production of progesterone was unaffected by indomethacin, which inhibits the production of arachidonate cycloxygenase metabolites such as prostaglandin E2. Our present data suggest that the presence of intrauterine bacterial infection may stimulate the intrauterine production of IL-2, and that the stimulation of IL-2 and the reduction of progesterone caused by IL-2 may in part explain the mechanism of uterine contraction associated with intrauterine infection during pregnancy.
Ohno
Y
Y
Department of Obstetrics and Gynecology, Nagoya University School of Medicine, Japan.
Kasugai
M
M
Kurauchi
O
O
Mizutani
S
S
Tomoda
Y
Y
D000653:Amniotic Fluid / Q000737:chemistry; D001424:Bacterial Infections / Q000150:complications / Q000276:immunology; D002821:Chorioamnionitis / Q000150:complications / Q000276:immunology; D046508:Culture Techniques; D015232:Dinoprostone / Q000096:biosynthesis*; D005321:Extraembryonic Membranes / Q000187:drug effects / Q000378:metabolism*; D005260:Female; D006801:Humans; D007213:Indomethacin / Q000494:pharmacology; D007375:Interleukin-1 / Q000494:pharmacology / Q000502:physiology; D007376:Interleukin-2 / Q000032:analysis / Q000494:pharmacology / Q000502:physiology*; D007752:Obstetric Labor, Premature / Q000209:etiology*; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000276:immunology; D011374:Progesterone / Q000096:biosynthesis*; D014590:Uterine Contraction / Q000502:physiology
D007375:Interleukin-1; D007376:Interleukin-2; D011374:Progesterone; D015232:Dinoprostone; D007213:Indomethacin